66.96 USD
-1.98 (-2.87%)
66.95 USD
-0.01 (-0.01%)
Overall DXCM gets a fundamental rating of 7 out of 10. We evaluated DXCM against 187 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make DXCM a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
DXCM had positive earnings in the past year.
In the past year DXCM had a positive cash flow from operations.
In the past 5 years DXCM has always been profitable.
In the past 5 years DXCM always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.61%, DXCM belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
Looking at the Return On Equity, with a value of 26.44%, DXCM belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
With an excellent Return On Invested Capital value of 15.72%, DXCM belongs to the best of the industry, outperforming 95.72% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DXCM is above the industry average of 8.80%.
The last Return On Invested Capital (15.72%) for DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
With an excellent Profit Margin value of 15.96%, DXCM belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
DXCM's Profit Margin has improved in the last couple of years.
DXCM has a Operating Margin of 18.41%. This is amongst the best in the industry. DXCM outperforms 90.37% of its industry peers.
In the last couple of years the Operating Margin of DXCM has grown nicely.
Looking at the Gross Margin, with a value of 60.20%, DXCM is in line with its industry, outperforming 59.89% of the companies in the same industry.
In the last couple of years the Gross Margin of DXCM has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DXCM is creating value.
DXCM has more shares outstanding than it did 1 year ago.
DXCM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DXCM has an improved debt to assets ratio.
2.2 Solvency
DXCM has an Altman-Z score of 5.05. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of DXCM (5.05) is better than 78.61% of its industry peers.
DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as DXCM would need 2.36 years to pay back of all of its debts.
DXCM has a Debt to FCF ratio of 2.36. This is amongst the best in the industry. DXCM outperforms 86.63% of its industry peers.
DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
DXCM has a Debt to Equity ratio (0.47) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.05 |
ROIC/WACC1.96
WACC8.04%
2.3 Liquidity
DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
DXCM has a Current ratio of 1.56. This is in the lower half of the industry: DXCM underperforms 72.19% of its industry peers.
A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.38, DXCM is not doing good in the industry: 61.50% of the companies in the same industry are doing better.
The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.41% over the past year.
DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.25% yearly.
The Revenue has grown by 14.21% in the past year. This is quite good.
Measured over the past years, DXCM shows a very strong growth in Revenue. The Revenue has been growing by 22.27% on average per year.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
DXCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.19% yearly.
DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.47% yearly.
EPS Next Y27.26%
EPS Next 2Y23.61%
EPS Next 3Y22.25%
EPS Next 5Y22.19%
Revenue Next Year15.38%
Revenue Next 2Y14.07%
Revenue Next 3Y13.72%
Revenue Next 5Y13.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.00, DXCM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 71.12% of the companies listed in the same industry.
DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.54.
With a Price/Forward Earnings ratio of 26.56, DXCM can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than 74.33% of the companies in the same industry.
DXCM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36 | ||
| Fwd PE | 26.56 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DXCM is valued a bit cheaper than 73.80% of the companies in the same industry.
83.96% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.59 | ||
| EV/EBITDA | 22.85 |
4.3 Compensation for Growth
DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
DXCM's earnings are expected to grow with 22.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)1.23
EPS Next 2Y23.61%
EPS Next 3Y22.25%
5. Dividend
5.1 Amount
DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
66.96
-1.98 (-2.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners99.51%
Inst Owner Change20.1%
Ins Owners0.19%
Ins Owner Change0.48%
Market Cap26.12B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.41
Price Target88.06 (31.51%)
Short Float %3.45%
Short Ratio2.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-13.77%
PT rev (3m)-16.45%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-4.79%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36 | ||
| Fwd PE | 26.56 | ||
| P/S | 5.78 | ||
| P/FCF | 24.59 | ||
| P/OCF | 18.03 | ||
| P/B | 9.58 | ||
| P/tB | 9.96 | ||
| EV/EBITDA | 22.85 |
EPS(TTM)1.86
EY2.78%
EPS(NY)2.52
Fwd EY3.76%
FCF(TTM)2.72
FCFY4.07%
OCF(TTM)3.71
OCFY5.54%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.32
PEG (5Y)1.23
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.05 |
F-Score5
WACC8.04%
ROIC/WACC1.96
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.26%
EPS Next 2Y23.61%
EPS Next 3Y22.25%
EPS Next 5Y22.19%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.38%
Revenue Next 2Y14.07%
Revenue Next 3Y13.72%
Revenue Next 5Y13.47%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.75%
EBIT Next 3Y36.37%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
What is the valuation status for DXCM stock?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
What are the PE and PB ratios of DEXCOM INC (DXCM) stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 36 and the Price/Book (PB) ratio is 9.58.